Skip to main content

Advertisement

Table 3 The univariate and multivariate analysis for post-procedural bleeding

From: Multicenter study on hemorrhagic risk of heparin bridging therapy for periendoscopic thromboprophylaxis

  Bleeding No bleeding Univariate (p value) Multivariate OR 95 % CI Multivariate (p value)
Age 72.2 ± 8.6 73.6 ± 8.5 0.40 0.26 0.01-9.30 0.45
Sex (M/F) 29/4 170/42 0.71    
Anticoagulants vs. Antiplatelet drugsa 21:12 114:98 0.28 1.36 0.61-3.17 0.45
Number of antithrombotic drugs Multiple vs. singlea 21:12 112:100 0.25 1.88 0.84-4.38 0.12
Type of heparin 32:1 207:5 0.81    
Unfractionated heparin vs. LMWH
Dose adjustment of HBT 17:16 36:176 <0.001 5.06 2.29-11.3 <0.001
Adjusted vs. Fixeda
Timing of antithrombotic resumption Appropriate vs. Inappropriate 16:17 119:93 0.51    
  1. OR: odds ratio, CI: confidence interval, LMWH: low molecular- weight heparin, HBT: heparin bridge therapy
  2. aControl in multivariate analysis